相关实验视频

Updated: Jun 8, 2025

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

在子宫内膜癌中KRAS突变:可能的预后和治疗影响

Karolina A Kilowski¹, Martin F Dietrich², Joanne Xiu³

¹Gynecologic Oncology Program, AdventHealth Cancer Institute, Orlando, FL, USA.

Gynecologic oncology

|November 5, 2024

概括

KRAS突变在子宫内膜癌 (EC) 中很常见,并且与预测免疫治疗反应的生物标志物有关. 这表明了高级EC患者潜在的新组合疗法.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
癌症研究癌症研究

背景情况:

再发性或转移性子宫内膜癌 (EC) 是一个重大的临床挑战,在标准疗法后,治疗选择有限.
KRAS突变 (KRAS-mut) 在其他固体瘤中表现有前途,但它们在EC中的作用仍未得到充分研究.

研究的目的:

为了确定在EC中KRAS突变的频率.
为了确定与KRAS-mut EC相关的基因组特征.
探索基于KRAS突变状态的EC潜在的新型治疗策略.

主要方法:

对7870个EC案件的大型分子数据库的分析.
查询致癌突变和免疫治疗生物标志物.
使用费雪精确/奇方测试和本杰明尼-霍赫伯格调整进行统计比较.

主要成果:

在16%的EC病例中发现了KRAS-mut,其中G12D和G12V是最常见的亚型.
KRAS-mut ECs显示微卫星不稳定性高 (MSI-high) 和瘤突变负担高 (TMB-high) 状态的患病率更高 (34.1%和36.5%).
在KRAS-mut和Her-2过度表达 (1.8%对13%) 之间观察到一个反向关联.

结论:

KRAS-mut定义了EC的一个独特的分子亚型.
KRAS-mut与MSI高和TMB高的同时发生表明了与免疫治疗结合的生物标志物驱动组合疗法的潜力.
进一步的临床试验是有必要的,以评估这些有针对性的策略在欧洲共同体.

关键词:

这是子宫内膜癌的癌症.免疫治疗是一种免疫疗法.在KRAS突变中发生突变.微卫星的不稳定性是微观的有针对性的治疗.瘤的突变负担

更多相关视频

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

相关概念视频

The Ras Gene

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...